Richard D. Scheyer

659 total citations
15 papers, 511 citations indexed

About

Richard D. Scheyer is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Richard D. Scheyer has authored 15 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 4 papers in Oncology. Recurrent topics in Richard D. Scheyer's work include Epilepsy research and treatment (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (3 papers). Richard D. Scheyer is often cited by papers focused on Epilepsy research and treatment (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (3 papers). Richard D. Scheyer collaborates with scholars based in United States, Canada and Germany. Richard D. Scheyer's co-authors include D. W. Paty, George P. Rice, Joyce A. Cramer, M. S. Freedman, Jeffrey A. Stewart, P. O’Connor, Christian Confavreux, Amit Bar‐Or, Richard H. Mattson and Amiram Katz and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Journal of Pharmaceutical Sciences.

In The Last Decade

Richard D. Scheyer

15 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard D. Scheyer United States 9 220 159 125 110 104 15 511
Juei-Jueng Lin Taiwan 9 188 0.9× 74 0.5× 97 0.8× 30 0.3× 146 1.4× 12 727
Mat D. Davis United States 11 101 0.5× 263 1.7× 30 0.2× 21 0.2× 230 2.2× 36 616
Liemin Zhou China 13 61 0.3× 264 1.7× 254 2.0× 81 0.7× 18 0.2× 49 667
Dario Maratea Italy 11 41 0.2× 79 0.5× 68 0.5× 51 0.5× 16 0.2× 41 434
Tony Waegemans France 7 15 0.1× 222 1.4× 205 1.6× 50 0.5× 110 1.1× 12 496
Bérenger Largeau France 10 22 0.1× 87 0.5× 39 0.3× 47 0.4× 74 0.7× 25 479
Karen S. Blisard United States 15 70 0.3× 34 0.2× 80 0.6× 26 0.2× 50 0.5× 41 566
George Belendiuk United States 9 18 0.1× 84 0.5× 75 0.6× 34 0.3× 316 3.0× 12 601
Joe Birkett United Kingdom 10 221 1.0× 42 0.3× 19 0.2× 111 1.0× 16 0.2× 16 470

Countries citing papers authored by Richard D. Scheyer

Since Specialization
Citations

This map shows the geographic impact of Richard D. Scheyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Scheyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Scheyer more than expected).

Fields of papers citing papers by Richard D. Scheyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Scheyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Scheyer. The network helps show where Richard D. Scheyer may publish in the future.

Co-authorship network of co-authors of Richard D. Scheyer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Scheyer. A scholar is included among the top collaborators of Richard D. Scheyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Scheyer. Richard D. Scheyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Moore, Kathleen N., Johanna C. Bendell, Anthony J. Olszanski, et al.. (2013). Phase I, first-in-human, open-label, dose-escalation study of U3-1565, a fully human anti-HB-EGF monoclonal antibody, in patients with advanced solid tumors.. Journal of Clinical Oncology. 31(15_suppl). 2519–2519. 1 indexed citations
2.
Senaldi, Giorgio, et al.. (2011). A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression. Critical Care. 15(S3). 1 indexed citations
3.
O’Connor, P., M. S. Freedman, Amit Bar‐Or, et al.. (2006). A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology. 66(6). 894–900. 269 indexed citations
4.
Scheyer, Richard D.. (1998). Chapter 23 Involvement of glutamate in human epileptic activities. Progress in brain research. 116. 359–369. 15 indexed citations
5.
Mattson, Richard H., et al.. (1998). Novel methods for studying new antiepileptic drug pharmacology.. PubMed. 76. 105–12. 4 indexed citations
6.
Scheyer, Richard D., et al.. (1995). Near‐Patient Rapid Assay of Phenytoin Concentration. Epilepsia. 36(11). 1152–1154. 2 indexed citations
7.
Scheyer, Richard D., et al.. (1995). Near-patient rapid assay of carbamazepine concentration. Journal of Epilepsy. 8(2). 99–103. 1 indexed citations
8.
Saygı, Serap, Susan S. Spencer, Richard D. Scheyer, et al.. (1994). Differentiation of Temporal Lobe Ictal Behavior Associated with Hippocampal Sclerosis and Tumors of Temporal Lobe. Epilepsia. 35(4). 737–742. 42 indexed citations
9.
Scheyer, Richard D., Joyce A. Cramer, & Richard H. Mattson. (1994). A Pharmacodynamic Approach to the Estimate of Carbamazepine Autoinduction. Journal of Pharmaceutical Sciences. 83(4). 491–494. 21 indexed citations
10.
Scheyer, Richard D., et al.. (1994). Phenytoin concentrations in the human brain: An in vivo microdialysis study. Epilepsy Research. 18(3). 227–232. 45 indexed citations
11.
Scheyer, Richard D., M. J. During, Dennis D. Spencer, Joyce A. Cramer, & R. H. Mattson. (1994). Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis. Neurology. 44(8). 1469–1469. 38 indexed citations
12.
Scheyer, Richard D., et al.. (1994). Simultaneous HPLC Analysis of Carbamazepine and Carbamazepine Epoxide in Human Brain Microdialysate. Journal of Liquid Chromatography. 17(7). 1567–1576. 10 indexed citations
13.
Scheyer, Richard D. & Richard H. Mattson. (1991). A method for prediction of phenytoin levels in the acute clinical setting. Computers and Biomedical Research. 24(6). 564–575. 4 indexed citations
14.
Marks, David, Amiram Katz, Richard D. Scheyer, & Susan S. Spencer. (1991). Clinical and electrographic effects of acute anticonvulsant withdrawal in epileptic patients. Neurology. 41(4). 508–508. 45 indexed citations
15.
Scheyer, Richard D. & Joyce A. Cramer. (1990). Pharmacokinetics of Antiepileptic Drugs. Seminars in Neurology. 10(4). 414–421. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juei-Jueng Lin Breakdown of academic impact, for papers by Mat D. Davis Breakdown of academic impact, for papers by Liemin Zhou Breakdown of academic impact, for papers by Dario Maratea Breakdown of academic impact, for papers by Tony Waegemans Breakdown of academic impact, for papers by Bérenger Largeau Breakdown of academic impact, for papers by Karen S. Blisard Breakdown of academic impact, for papers by George Belendiuk Breakdown of academic impact, for papers by Joe Birkett
Rankless by CCL
2026